| 1 | [SID125306013] | Active | IC50 | 3.179 | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651720, Type: confirmatory] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | IC50 | 3.179 [uM] | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651720 | | BioAssay type | confirmatory | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 2 | [SID125306013] | Active | IC50 | 3.179 | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651720, Type: confirmatory] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | IC50 | 3.179 [uM] | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651720 | | BioAssay type | confirmatory | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 3 | [SID125306013] | Active | IC50 | 3.179 | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651720, Type: confirmatory] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | IC50 | 3.179 [uM] | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651720 | | BioAssay type | confirmatory | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 4 | [SID125306013] | Active | IC50 | 4.286 | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) [AID651672, Type: confirmatory] | PLIN1 gene product [Homo sapiens] [gi:223718203] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | IC50 | 4.286 [uM] | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) | | AID | 651672 | | BioAssay type | confirmatory | | Target | PLIN1 gene product [Homo sapiens] [gi:223718203] | | PubMed | | | Data Table |  |
|
| 5 | [SID125306013] | Active | IC50 | 4.813 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID651677, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | IC50 | 4.813 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 651677 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 6 | [SID125306013] | Active | IC50 | 8.16 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) produced in HEK293T cells [AID651733, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | IC50 | 8.16 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) produced in HEK293T cells | | AID | 651733 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 7 | [SID125306013] | Active | | | Luminescence-based biochemical high throughput confirmation assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID651612, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput confirmation assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 651612 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 8 | [SID125306013] | Active | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID602281, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 602281 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 9 | [SID125306013] | Active | | | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex [AID652068, Type: screening] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | BioAssay | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex | | AID | 652068 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID125306013] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID125306013] | Active | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 12 | [SID125306013] | Inactive | | | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen [AID651550, Type: screening] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen | | AID | 651550 | | BioAssay type | screening | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 13 | [SID125306013] | Inactive | | | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen [AID651550, Type: screening] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen | | AID | 651550 | | BioAssay type | screening | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 14 | [SID125306013] | Inactive | | | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen [AID651550, Type: screening] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen | | AID | 651550 | | BioAssay type | screening | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 15 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 16 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 17 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 18 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 19 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 20 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 21 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 22 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 23 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 24 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 25 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 26 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 27 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 28 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 29 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 30 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 31 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 32 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 33 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 34 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 35 | [SID125306013] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 36 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 37 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 38 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 39 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 40 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 41 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 42 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 43 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 44 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 45 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 46 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 47 | [SID125306013] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 48 | [SID125306013] | Inactive | | | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay [AID651636, Type: screening] | GPR183 gene product [Homo sapiens] [gi:4826706] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay | | AID | 651636 | | BioAssay type | screening | | Target | GPR183 gene product [Homo sapiens] [gi:4826706] | | PubMed | | | Data Table |  |
|
| 49 | [SID125306013] | Inactive | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 50 | [SID125306013] | Inactive | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 125306013 | | CID | 53383340 | | Outcome | Inactive | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|